University of Edinburgh
Scottish Liquid Biopsy Startup BioCaptiva Raises £1M in Seed Funding
The firm, a University of Edinburgh spinout, will use the funding to in-license its BioCollector liquid biopsy platform and launch initial trials.
The European Commission awarded a consortium of private companies and academic researchers €759,000 recently to carry out their plans.
The company in partnership with the University of Edinburgh recently completed a trial of the test involving 400 patients.
VALUE-Dx involves six IVD companies and is being heralded by participants as an opportunity for competitors to work together to improve test adoption.
While the first task of the centers will be to digitize their workflows to improve efficiency, they also aim to eventually develop new AI-based analytical tools for diagnosing patients.
Nov 17, 2017